Scientists may have found a true cure for cancer, and they are planning to carry out testing and experimentation this 2018. The process involves extracting blood from people who "miraculously" got cured from cancer and using elements in the blood to completely cure a person of the said disease.
A biotech startup called LIfT Biosciences is pioneering the idea. The name came from the method of delivering "innate immunity" via Leukocyte Infusion Therapy, or "LIft."
The process will involve the use of neutrophil cells. These cells are some of the first cells that defend against foreign elements in human anatomy. The cells combat cancer through the use of chemicals and antibodies that destroy cancer cells.
Initial tests of the method prove positive results. According to Express, further testing on humans may start on 2018.
LIfT Biosciences Chief Executive Alex Blyth was confident with the treatment method. He said that the process will not just be a better treatment for cancer, but will be a cure that the patient will receive in the course of five or six weeks.
He also said that basing on their mouse and model experiments, they expect humans to experience complete remission by the time the treatment is done.
The company claimed that the transfusion will be relatively safe, as there were no threats of "serious rejections" through the transfer of neutrophil.
Blyth explained that the blood will only be present in the patient's body for five days at most. This means that the foreign blood will be out before the body's immune system recognizes the difference.
"Our ultimate aim is to create the world's first cell bank of immensely powerful cancer killing neutrophils," Blyth added.
However, the cure is still in experimental stage, and there is no assurance that it will be truly effective.
